3,4-Dichloromethylphenidate

3,4-DCMP
Clinical data
Routes of; administration	oral, insufflation, rectal
ATC code	none;
Legal status
Legal status	CA: Schedule III; DE: NpSG (Industrial and scientific use only); UK: Class B;
Pharmacokinetic data
Metabolism	Primarily by the liver
Excretion	Predominantly renal
Identifiers
	IUPAC name Methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate;
CAS Number	1400742-68-8 ;
PubChem CID	44418862;
ChemSpider	23278471 ;
UNII	F7LN3N6ZLA;
CompTox Dashboard (EPA)	DTXSID30658831 ;
Chemical and physical data
Formula	C14H17Cl2NO2
Molar mass	302.20 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC(=O)C(c1ccc(c(c1)Cl)Cl)C2CCCCN2;
	InChI InChI=1S/C14H17Cl2NO2/c1-19-14(18)13(12-4-2-3-7-17-12)9-5-6-10(15)11(16)8-9/h5-6,8,12-13,17H,2-4,7H2,1H3 ; Key:JUKMAYKVHWKRKY-UHFFFAOYSA-N ;
	(what is this?) (verify)

3,4-dichloromethylphenidate (abbreviated as 3,4-DCMP, and incorrectly as 3,4-CTMP for the d,l-threo diastereomer) is a potent stimulant drug from the phenidate class closely related to methylphenidate. It acts as a potent serotonin-norepinephrine-dopamine reuptake inhibitor with a long duration of action. It has been sold online as a designer drug.